发明申请
- 专利标题: Protein modification and maintenance molecules
- 专利标题(中): 蛋白质修饰和维持分子
-
申请号: US10473451申请日: 2002-04-05
-
公开(公告)号: US20050019763A1公开(公告)日: 2005-01-27
- 发明人: Ameena Gandhi , Angelo Delegeane , Anita Swarnakar , April Hafalia , Brendan Duggan , Bridget Warren , Brooke Emerling , Chandra Arvizu , Cynthia Honchell , Deborah Kallick , Dyung Lu , Ernestine Lee , Henry Yue , Ian Forsythe , Jayalaxmi Ramkumar , Jennifer Griffin , Joana Li , Kavitha Thangavelu , Mariah Baughn , Monique Yao , Madhusudan Sanjanwala , Narinder Chawla , Neil Burford , Preeti Lal , Shanya Becha , Soo Lee , Vicki Elliott , Wen Luo , Yan Lu , Yu-mei Wang
- 申请人: Ameena Gandhi , Angelo Delegeane , Anita Swarnakar , April Hafalia , Brendan Duggan , Bridget Warren , Brooke Emerling , Chandra Arvizu , Cynthia Honchell , Deborah Kallick , Dyung Lu , Ernestine Lee , Henry Yue , Ian Forsythe , Jayalaxmi Ramkumar , Jennifer Griffin , Joana Li , Kavitha Thangavelu , Mariah Baughn , Monique Yao , Madhusudan Sanjanwala , Narinder Chawla , Neil Burford , Preeti Lal , Shanya Becha , Soo Lee , Vicki Elliott , Wen Luo , Yan Lu , Yu-mei Wang
- 优先权: US60282282 20010405; US60283782 20010413; US60284823 20010418; US60287264 20010427; US60288662 20010504; US60290383 20010511; US60298348 20010615; US60351928 20020125; US60359903 20020225
- 国际申请: PCT/US02/10812 WO 20020405
- 主分类号: G01N33/50
- IPC分类号: G01N33/50 ; A61K38/00 ; A61K45/00 ; A61K49/00 ; A61P1/00 ; A61P9/00 ; A61P15/00 ; A61P25/00 ; A61P29/00 ; A61P35/00 ; A61P37/06 ; A61P43/00 ; C07K14/47 ; C07K16/18 ; C12M1/00 ; C12N1/15 ; C12N1/19 ; C12N1/21 ; C12N5/10 ; C12N9/64 ; C12N15/09 ; C12P21/02 ; C12P21/08 ; C12Q1/68 ; G01N33/15 ; G01N33/53 ; G01N37/00 ; A01K67/00 ; C07H21/04
摘要:
The invention provides human protein modification and maintenance molecules (PMOD) and polynucleotides which identify and encode PMOD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMOD.